Apr 30, 2020
Targovax ASA Appoints Dr Victor Levitsky as Chief Scientific Officer
Jan 23, 2020
CStone successfully hosted the first U.S. R&D Day in New York
Oct 11, 2019
Allergan and Molecular Partners Present Late-Breaking Data from Phase 3 Studies of Investigational Abicipar pegol in Neovascular Wet Age-Related Macular Degeneration
Aug 19, 2019
Abstract on CStone's CS1001-101 trial accepted for poster presentation at ESMO 2019 Annual Congress
Apr 04, 2019
CStone Pharmaceuticals presented poster of pre-clinical result for CS1003 at AACR
Apr 02, 2019
Allergan and Molecular Partners Announce Topline Safety Results from MAPLE study of Abicipar pegol
Dec 18, 2018
Amgen And Molecular Partners Announce Strategic Collaboration In Immuno-Oncology
Jul 19, 2018
Allergan and Molecular Partners Announce Two Positive Phase 3 Clinical Trials for Abicipar pegol 8 and 12-week Regimens for the Treatment in Patients with Neovascular Age-Related Macular Degeneration
Jun 15, 2018
Gene Therapy for Age-related Macular Degeneration Pipeline Analysis Report 2018 Featuring RetroSense Therapeutics, REGENXBIO & AGTC
Jun 12, 2018
Global Macular Degeneration (AMD) and Other Retinal Diseases Drugs Industry and Market 2018-2028 - Visiongain Report
Dec 19, 2017
GigaGen to Develop Human Antibodies Against 17 Immuno-oncology Targets
Sep 28, 2017
Medicenna Updates On-Going Phase 2b Clinical Trial Protocol for Recurrent Glioblastoma
Jun 07, 2017
Macular Degeneration (AMD) and Other Retinal Diseases: World Drug Industry and Market 2016-2026